Research ArticleNuclear Oncology
Radiotoxicity After Iodine-131 Therapy for Thyroid Cancer Using the Micronucleus Assay
Naoto Watanabe, Kunihiko Yokoyama, Seigo Kinuya, Noriyuki Shuke, Masashi Shimizu, Ryusuke Futatsuya, Takatoshi Michigishi, Norihisa Tonami, Hikaru Seto and David A. Goodwin
Journal of Nuclear Medicine March 1998, 39 (3) 436-440;
Naoto Watanabe
Kunihiko Yokoyama
Seigo Kinuya
Noriyuki Shuke
Masashi Shimizu
Ryusuke Futatsuya
Takatoshi Michigishi
Norihisa Tonami
Hikaru Seto
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radiotoxicity After Iodine-131 Therapy for Thyroid Cancer Using the Micronucleus Assay
Naoto Watanabe, Kunihiko Yokoyama, Seigo Kinuya, Noriyuki Shuke, Masashi Shimizu, Ryusuke Futatsuya, Takatoshi Michigishi, Norihisa Tonami, Hikaru Seto, David A. Goodwin
Journal of Nuclear Medicine Mar 1998, 39 (3) 436-440;
Radiotoxicity After Iodine-131 Therapy for Thyroid Cancer Using the Micronucleus Assay
Naoto Watanabe, Kunihiko Yokoyama, Seigo Kinuya, Noriyuki Shuke, Masashi Shimizu, Ryusuke Futatsuya, Takatoshi Michigishi, Norihisa Tonami, Hikaru Seto, David A. Goodwin
Journal of Nuclear Medicine Mar 1998, 39 (3) 436-440;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with 131I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
- The Radiotoxicity of 131I Therapy of Thyroid Cancer: Assessment by Micronucleus Assay of B Lymphocytes